Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Cryptogenic stroke in a patient with a PFO: a decision analysis.

Stern S, Cohen MJ, Gilon D, Leshno M, Brezis M.

Am J Med Sci. 2008 Jun;335(6):457-64. doi: 10.1097/MAJ.0b013e3181592278.

PMID:
18552576
2.

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.

Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.

Eur Heart J. 2013 Nov;34(43):3342-52. doi: 10.1093/eurheartj/eht285. Epub 2013 Jul 11. Review.

PMID:
23847132
3.

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.

JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16. Review.

4.

PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.

Ntaios G, Papavasileiou V, Makaritsis K, Michel P.

Int J Cardiol. 2013 Oct 30;169(2):101-5. doi: 10.1016/j.ijcard.2013.08.058. Epub 2013 Aug 28. Review.

PMID:
24041984
5.

Prevention of recurrent stroke in patients with patent foramen ovale.

Wessler BS, Kent DM.

Neurol Clin. 2015 May;33(2):491-500. doi: 10.1016/j.ncl.2015.01.002. Epub 2015 Feb 28. Review.

6.

Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials.

Hakeem A, Marmagkiolis K, Hacioglu Y, Uretsky BF, Gundogdu B, Leesar M, Bailey SR, Cilingiroglu M.

Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):349-55. doi: 10.1016/j.carrev.2013.08.010. Epub 2013 Sep 27. Review.

PMID:
24080379
7.

Closure of patent foramen ovale in cryptogenic stroke: a never ending story.

Calvet D, Mas JL.

Curr Opin Neurol. 2014 Feb;27(1):13-9. doi: 10.1097/WCO.0000000000000052. Review. Erratum in: Curr Opin Neurol. 2014 Apr;27(2):242.

PMID:
24300793
8.

Patent foramen ovale: thromboembolic structure or incidental finding?

Torbey E, Thompson PD.

Conn Med. 2011 Feb;75(2):97-105. Review.

PMID:
21476380
9.

Current status of percutaneous PFO closure.

Rohrhoff N, Vavalle JP, Halim S, Kiefer TL, Harrison JK.

Curr Cardiol Rep. 2014 May;16(5):477. doi: 10.1007/s11886-014-0477-4. Review.

PMID:
24633647
10.

Cardiac procedures to prevent stroke: patent foramen ovale closure/left atrial appendage occlusion.

Freixa X, Arzamendi D, Tzikas A, Noble S, Basmadjian A, Garceau P, Ibrahim R.

Can J Cardiol. 2014 Jan;30(1):87-95. doi: 10.1016/j.cjca.2013.11.008. Epub 2013 Nov 15. Review.

PMID:
24365193
11.

Patent foramen ovale--assessment and treatment.

Irwin B, Ray S.

Cardiovasc Ther. 2012 Jun;30(3):e128-35. doi: 10.1111/j.1755-5922.2010.00250.x. Epub 2011 Feb 15. Review.

PMID:
21883994
12.

Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.

Patti G, Pelliccia F, Gaudio C, Greco C.

Am J Cardiol. 2015 Mar 15;115(6):837-43. doi: 10.1016/j.amjcard.2014.12.051. Epub 2015 Jan 6. Review.

PMID:
25620037
13.

[Percutaneous closure of patent foramen ovale: a wise approach].

Gaspardone A, Iani C, Papa M.

G Ital Cardiol (Rome). 2008 Sep;9(9):593-602. Review. Italian.

PMID:
18783080
14.

Cryptogenic stroke and patent foramen ovale.

Thaler DE, Saver JL.

Curr Opin Cardiol. 2008 Nov;23(6):537-44. doi: 10.1097/HCO.0b013e32831311bd. Review.

PMID:
18830067
15.

Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.

Nagaraja V, Raval J, Eslick GD, Burgess D, Denniss AR.

Heart Lung Circ. 2013 Nov;22(11):903-9. doi: 10.1016/j.hlc.2013.07.022. Epub 2013 Sep 10. Review.

PMID:
24035325
16.

Management of patients with stroke and a patent foramen ovale.

Rodriguez CJ, Homma S.

Curr Neurol Neurosci Rep. 2004 Jan;4(1):19-22. Review.

PMID:
14683623
17.

Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.

Peña JM, Kizer JR.

Curr Atheroscler Rep. 2013 Jul;15(7):338. doi: 10.1007/s11883-013-0338-4. Review.

PMID:
23715857
18.

New aspects of paradoxical embolism.

Lehmeyer S, Lindhoff-Last E.

Vasa. 2011 Jan;40(1):31-40. doi: 10.1024/0301-1526/a000067. Review.

PMID:
21283971
19.

Management of patients with stroke and a patent foramen ovale.

Rodriguez CJ, Homma S.

Curr Cardiol Rep. 2004 Mar;6(2):143-6. Review.

PMID:
14759360
20.

Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis.

Wolfrum M, Froehlich GM, Knapp G, Casaubon LK, DiNicolantonio JJ, Lansky AJ, Meier P.

Heart. 2014 Mar;100(5):389-95. doi: 10.1136/heartjnl-2013-304394. Epub 2013 Jun 21. Review.

PMID:
23793373

Supplemental Content

Support Center